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high blood glucose levels, and was on
cytotoxic chemotherapy for previous
6 months. The risk for intestinal
injury is high in severe liver disease
and cytotoxic chemotherapy.
Intestinal mucosal compromise may
potentiate translocation of C. tertium
to systemic circulation and metastatic
foci. The second patient had no pre-
disposing medical history before the
present episode that might have
resulted in acquisition of C. tertium
from the soil. Both patients had
pyrexia, necrotizing fasciitis, and gan-
grene of a lower limb with C. tertium
as the sole bacterial isolate. Neither
patient had neutropenia when they
were first seen. This contrasts with
earlier reports of C. tertium infections
(predominantly bacteremia), which
usually occurred in patients with pre-
existing neutropenia (3). Both patients
improved with penicillin or van-
comycin and metronidazole, and both
isolates were susceptible to these
three antibiotics in vitro. Therefore,
we consider both isolates to be clini-
cally important. The pathogenesis of
infection caused by C. tertium is not
well understood, since the organism
does not produce exotoxins. No evi-
dence exists to correlate oxygen sen-
sitivity with bacterial enzyme produc-
tion and pathogenicity in aerotolerant
clostridia. Our report adds to the list
of recently emerging diseases caused
by  C. tertium. The growing accept-
ance of this organism as a human
pathogen will lead to better delin-
eation and understanding of its patho-
genic potential.
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Dengue
Hemorrhagic Fever,
Uttaradit, Thailand 
To the Editor: Dengue hemor-
rhagic fever (DHF) has been recog-
nized as a disease of young children in
the past. Three decades ago most
reported case-patients in Thailand
were 3–6 years of age (1). Increasing
evidence shows that the age group
most affected is changing (2). We
report evidence that in Uttaradit,
Thailand, the predominant age of
those who acquire DHF has increased
by at least 2 years during the 1990s.
Uttaradit is a province in the north-
ern part of Thailand. DHF is endemic
in Uttaradit, as it is in most parts of
the country. Between 1992 and 2001,
three major outbreaks of DHF
occurred, in 1993, 1998, and 2001.
The number of DHF cases report-
ed to the Provincial Health Office
from January 1992 to December 2001
(classified by age groups) was used as
the estimated annual DHF incidence.
Case definition and categorization
followed the International Statistical
Classification of Diseases and Related
Health Problems (ICD-10). DHF cat-
egories reported in this study included
both DHF without shock and the
dengue shock syndrome (the number
of cases and deaths combined).
Dengue fever, a milder disease mani-
festation, was not included.
The age distribution of DHF cases
showed that, in the 1993 epidemic,
children 5–9 years of age had the
largest proportion of cases, whereas in
2001, the peak age of those infected
was 10–14 years. The transitional
stage (mean age 11.3 years) was
observed in 1998.
During the observed period, the
annual mean age of DHF case-
patients ranged from 8.4 to 15.1 years.
Despite some fluctuation, the mean
age of DHF case-patients was <10
years of age before 1996. From 1997
onward, the mean age was consistent-
ly >10 years.
The incidence of DHF in children
<4 years of age decreased from
586.0/100,000 in the 1993 epidemic
to 197.5/100,000 in 2001. The inci-
dence in children 5–9 years of age
also decreased from 1,330.3/100,000
to 676.6/100,000 in the corresponding
years. While the incidence in children
10–14 years of age remained
unchanged, the incidence in those
15–24 years of age increased from
122.8/100,000 to 323.5/100,000, and
from 20.0 to 52.6 per 100,000, a more
than twofold increase. 
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creased from 10.0 years in the 1993
epidemic to 11.3 years in 1998 and to
13.2 years in 2001, as a consequence
of a decrease in the incidence among
children <9 years, and an increase in
the incidence among the older age
groups. This finding was similar to
what had been observed earlier in
Singapore and Indonesia (2,3).
Some researchers have found that
when the average number of annual
dengue infections declines, the chance
of persons acquiring dengue infections
declines, resulting in delays in the age
when a person has experienced the
first, then second, dengue infection
(4). However, in Uttaradit, as well as
in other parts of Thailand, dengue
infection is endemic, with large out-
breaks occurring at 2- to 3-year inter-
vals: later epidemics have also shown
an increase in the overall incidence
rates. Thus, this explanation is unlike-
ly to be the reason for a shift in the age
distribution of DHF in Uttaradit.
We reviewed information that indi-
cated that the shift in age predomi-
nance could be caused by  the changes
in places of transmission. Among
these was the study in Singapore,
which proposed that an effective mos-
quito-control program in households
had resulted in changes in which age
group had the largest number of DHF
cases (5). A significant (p<0.001) rise
in seroconversion in children >6 years
of age coincided with the start of for-
mal schooling. The likelihood of
dengue infection increased with time
spent away from home, suggesting
that the location where dengue was
acquired may have changed (5). The
recent study in Thailand also suggest-
ed that, although dengue infection
may be transmitted in the home envi-
ronment, transmission within schools
may also be important (6).
The changing of the population
age structure also explained the age
shifting phenomenon in some studies
(7). In Uttaradit, however, changes in
the age structure of the population
were small from 1992 to 2001.
The intervening effect of vaccina-
tion against Japanese encephalitis
virus, a different but related fla-
vivirus, could also explain why the
mean age for most cases of DHF
increased. Cross-reaction between
dengue virus and Japanese encephali-
tis virus is well established (8).
Vaccination against Japanese
encephalitis virus may temporarily
protect persons, primarily young chil-
dren, against dengue infection or at
least reduce its severity, resulting in a
decline in the observed incidence. The
cohort of these vaccine recipients
were then exposed to dengue infec-
tion later in life and exhibited diseases
when they shifted into an older age
group. An increase of Japanese
encephalitis vaccine coverage from
96% in 1995 to 100% in 2001 (9)
appeared to confirm the above expla-
nation. Nevertheless, areas where
Japanese encephalitis vaccination had
not been implemented also experi-
enced a change in the age group with
the most DHF. A final alternative
explanation is the effect of herd
immunity. Some researchers have
observed that in places where dengue
does not occur yearly, older age
groups have higher rates of infection
(10). However, dengue cases had been
reported every year in Uttaradit, and
the intervals between each epidemic
were not long. We therefore, believed
that the herd immunity hypothesis did
not explain the observed changing age
predominance in our study.
The mean age of DHF case-
patients in Uttaradit, Thailand,
increased by >3 years between 1992
and 2001. This phenomenon may be
important from a public health stand-
point, as community and health-relat-
ed personnel may still perceive DHF
as a disease of only small children and
unintentionally leave older children
less protected or ignored. Further
study is needed to confirm that the age
group shifting of DHF predominance
can be explained by the changes in
locations where disease transmission
takes place and possibly by effective
household mosquito- elimination pro-
grams. 
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Antimicrobial 
Drug–resistant
Salmonella
Typhimurium
(Reply to Helms)
In Reply to Helms: In the article
by Helms et al., Helms concludes that
infections with Salmonella  Typhim-
urium strains resistant to ampicillin,
chloramphenicol, streptomycin, sul-
fonamide, and tetracycline (hereafter
referred to as penta-resistant) were
associated with higher death rates than
infections with non–penta-resistant S.
Typhimurium. Helms also concluded
that infections with quinolone-resist-
ant (nalidixine-resistant) S. Typhimu-
rium were associated with higher
death rates than quinolone-susceptible
S. Typhimurium (1).
Table 2 in Helms’ article provides
information that enables close scruti-
ny of this conclusion and comparison
of the excess mortality associated
with penta-resistant, quinolone-sus-
ceptible  S.  Typhimurium with the
excess mortality of non–penta-resist-
ant S. Typhimurium (1). In this letter,
the Table is based on the original
table. However, two additional com-
parisons have been added: the p val-
ues, which are not based on the data
but are approximations based on the
parameters in the table. 
The conclusion is that only
quinolone resistance is associated
with excess mortality compared with
nonresistant isolates. Penta-resistant,
quinolone-susceptible  S.  Typhim-
urium has a risk ratio of 2.9 (1.1 to
7.9) compared to the ratio of
non–penta-resistant isolates 2.1 (1.5
to 2.9). When these figures are com-
pared, the approximate p value is
0.55, which, of course, is far from
being significant. Thus, on the basis
of the article by Helms, penta resist-
ance may not pose a greater threat to
human health than non–penta resist-
ance. However, the measured effect of
penta resistance is achieved by the
inclusion of quinolone-resistant S.
Typhimurium in the group. 
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Antimicrobial 
Drug–resistant
Salmonella
Typhimurium
(Reply to Dahl)
In Reply to Dahl: The emergence
and spread of multidrug-resistant
Salmonella enterica  serovar
Typhimurium DT104 (MDR DT104)
contributed to an international
increase in antimicrobial drug resist-
ance in S. Typhimurium in the late
1990s (1,2). This type of Salmonella
is usually resistant to five drugs:
ampicillin, chloramphenicol, strepto-
mycin, sulfonamides, and tetracycline
(R-type ACSSuT) and easily acquires
resistance to other drugs, including
quinolones, trimethoprim, and amino-
glycosides (1,3–5). To determine
death rates after infection with MDR
DT104 or closely related strains, we
identified patients who were infected
with strains at least resistant to
ACSSuT (6). Analysis limited to
strains that were only R-type ACSSuT
would have given a misleading result
since MDR DT104 often, as men-
tioned, develops additional resistance
to other classes of antimicrobial drugs
in addition to the ACSSuT-complex.
This fact needs to be taken into
account in any attempt to quantify the
overall public health impact of MDR
DT104 and related strains.
We found, in our matched cohort
study (6), that 283 patients infected
with strains resistant to at least
ACSSuT were 4.8 times more likely
to die than the general Danish popula-
tion, compared with 2.3 for 953
patients infected with pansusceptible
strains. This difference in death rates
ocurred mainly because 40 of the 283
strains had R-type ACSSuTNx (i.e.,
additional resistance to nalidixic
acid), and infection with this strain in
particular is associated with a high
death rate (relative mortality 13.1). As
Dahl suggests, infection with R-type
ACSSuT (Nx susceptible) was not
Table. Table showing additional comparisons (1)
a 
Resistant  Susceptible 
 
Deaths/ 
cases  RR
b  (95% CI) 
Deaths/ 
cases  RR
b (95 % CI)  p value 
Penta with and 
without quinolone 
12/283  4.8 (2.2 to 10.5)  47/1,764  2.1 (1.5 to 2.9)  0.06 
Penta with 
quinolone 
5/40  13.1 (3.3 to 51.9)  47/1,764  2.1 (1.5 to 2.9)
c  0.01
d 
Penta without 
quinolone 
7/243  2.9 (1.1 to 7.9)  47/1764  2.1 (1.5 to 2.9)
c  0.55c
d 
aRR, relative risk; CI, confidence interval. 
bAdjusted for coexisting conditions.
 
cCompared to the non-penta group. 
dApproximations based on the parameters from the table. 